0 Commentaires
0 Parts
535 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
Dopamine Beta Hydroxylase Deficiency Market Size, Share, Industry Trends, Growth Drivers and Forecast Report 2026–2033" According to the latest report published by Data Bridge Market Research, the Dopamine Beta Hydroxylase Deficiency Market The dopamine beta hydroxylase deficiency market is expected to witness market growth at a rate of 6.00% in the forecast period of 2022 to 2029. Dopamine Beta Hydroxylase Deficiency Market research report has been structured. The report assesses ongoing as...0 Commentaires 0 Parts 27 Vue 0 Aperçu
-
Emerging Demands in the Global Non-Cardioselective Beta Blockers Market: Comprehensive Segment Analysis and Forecast, 2026-2033According to the latest report published by Data Bridge Market Research, the Non-Cardioselective Beta Blockers Market The global non-cardioselective beta blockers market size was valued at USD 3.50 billion in 2025 and is expected to reach USD 5.09 billion by 2033, at a CAGR of4.80% during the forecast period A number of aspects that are kept into view while creating an...0 Commentaires 0 Parts 210 Vue 0 Aperçu
-
Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market Share and Size Report, Emerging Trends and Forecast Analysis"Executive Summary Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market Research: Share and Size Intelligence The Europe alpha and beta emitters based radiopharmaceuticals market size was valued at USD 215.99 million in 2024 and is expected to reach USD 465.84 million by 2032, at a CAGR of 10.1% during the forecast period The all-inclusive Europe Alpha...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
GSK-3β Inhibitors Therapeutics Market Report: Drug Discovery Trends"According to the latest report published by Data Bridge Market Research, the Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market The global glycogen synthase kinase 3 beta (GSK-3β) inhibitors therapeutics market size was valued at USD 2.19 billion in 2024 and is projected to reach USD 3.29 billion by 2032, with a CAGR of 5.20% during the forecast period...0 Commentaires 0 Parts 11 Vue 0 Aperçu
-
TGF-β Pathway Targeted Anti-Fibrotic Drug Market Trends Driving Future Industry Growth"According to the latest report published by Data Bridge Market Research, the TGF-β Pathway Targeted Anti-Fibrotic Drug Market The global TGF-β Pathway Targeted Anti-Fibrotic Drug market size was valued at USD 2.18 billion in 2025and is expected to reach USD 7.86 billion by 2033, at a CAGR of 17.40% during the forecast period. The persuasive TGF-β...0 Commentaires 0 Parts 284 Vue 0 Aperçu
-
The "Viral Frontier": Is 2026 the Year Interferon Beta Moves Beyond MS?A major shift in the 2026 global industry is the record-breaking research into "Interferon-Based Antivirals." This year, to cater to "Pandemic Preparedness" initiatives, the Interferon Beta Drugs Market is exploring Intranasal Prophylactics to fight off respiratory viral threats. This level of "Emergency Versatility" is the new frontier, expanding the use of these drugs from specialized...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek